aTyr Pharma ATYR Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's non-cash lease expense?
- aTyr Pharma (ATYR) reported non-cash lease expense of $232K in Q1 2026.
- How has aTyr Pharma's non-cash lease expense changed year-over-year?
- aTyr Pharma's non-cash lease expense increased by 7.4% year-over-year, from $216K to $232K.
- What is the long-term trend for aTyr Pharma's non-cash lease expense?
- Over 3 years (2021 to 2025), aTyr Pharma's non-cash lease expense has grown at a 2.4% compound annual growth rate (CAGR), from $829K to $889K.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.